Peripheral Neuropathy Due to Chemotherapy Clinical Trials

9 recruiting

Peripheral Neuropathy Due to Chemotherapy Trials at a Glance

9 actively recruiting trials for peripheral neuropathy due to chemotherapy are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Houston, Boston, and Dallas. Lead sponsors running peripheral neuropathy due to chemotherapy studies include M.D. Anderson Cancer Center, Ka-Wai Ho, and Fox Chase Cancer Center.

Browse peripheral neuropathy due to chemotherapy trials by phase

Treatments under study

About Peripheral Neuropathy Due to Chemotherapy Clinical Trials

Looking for clinical trials for Peripheral Neuropathy Due to Chemotherapy? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peripheral Neuropathy Due to Chemotherapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peripheral Neuropathy Due to Chemotherapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Closed Loop Spinal Cord Stimulation for Chemotherapy Induced Peripheral Neuropathy, a Pilot Study.

Peripheral Neuropathy Due to Chemotherapy
M.D. Anderson Cancer Center10 enrolled1 locationNCT06616649
Recruiting
Phase 3

Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy, Chemotherapy-induced
Qinghai Red Cross Hospital326 enrolled4 locationsNCT07423390
Recruiting
Not Applicable

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NeuropathyPeripheral NeuropathyPeripheral Neuropathy Due to Chemotherapy+1 more
Ka-Wai Ho60 enrolled2 locationsNCT07095998
Recruiting
Not Applicable

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathy With Type 2 DiabetesPeripheral Neuropathies+2 more
RxFunction Inc.200 enrolled6 locationsNCT06959277
Recruiting
Early Phase 1

Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study

Peripheral Neuropathy Due to Chemotherapy
M.D. Anderson Cancer Center20 enrolled1 locationNCT06744816
Recruiting
Not Applicable

Patient-identified Values as Outcome Targets (PIVOT) Feasibility Pilot Trial

Peripheral Neuropathy Due to Chemotherapy
M.D. Anderson Cancer Center45 enrolled1 locationNCT06736600
Recruiting
Early Phase 1

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Metastatic Colorectal Cancer (CRC)Oxaliplatin Induced Peripheral Neuropathy in Cancer PatientsPeripheral Neuropathy Due to Chemotherapy
Fox Chase Cancer Center30 enrolled1 locationNCT07167446
Recruiting

Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Peripheral Neuropathy Due to Chemotherapy
Texas Woman's University40 enrolled1 locationNCT06313359
Recruiting
Phase 2

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Peripheral Neuropathy Due to Chemotherapy
Medical College of Wisconsin40 enrolled1 locationNCT03571334